The DOI matches its Crossref record.
Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation?
Abstract
The autoimmune response that leads to destruction of pancreatic islet β-cells and insulin-dependent diabetes mellitus (IDDM) has a genetic basis; however, environmental factors can exert profound modulating effects on the genetic predisposition to this autoimmune response. Recent studies in animal models for human IDDM, the genetically diabetes-prone NOD mouse and BB rat, have revealed that microbial agents—including certain viruses and extracts of bacteria, fungi, and mycobacteria—often have a protective action against diabetes development. Many of these microbial preparations are immune adjuvants, which are agents that stimulate the immune system. The protective effects of these agents against diabetes appear to involve perturbations in the production of cytokines, which are polypeptides produced by and acting on cells of the immune system. Thus, recent studies in NOD mice suggest that the islet β-cell-directed autoimmune response may be mediated by a T-helper 1 (Th1) subset of T-cells producing the cytokines interleukin-2 (IL-2) and interferon-γ. These studies also suggest that the diabetes-protective effects of administering microbial agents, adjuvants, and a β-cell autoantigen (GAD65 [glutamic acid decarboxylase]) may result from activation of a Th2 subset of T-cells that produce the cytokines IL-4 and IL-10 and consequently downregulate the Th1-cell-mediated autoimmune response. The clinical implication of these findings is that the autoimmune response leading to islet β-cell destruction and IDDM may be amenable to prevention or suppression by therapeutic interventions aimed at stimulating the host's own immunoregulatory mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Cytokine gene polymorphism in human disease: on-line databases
Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M., Oksenberg, J., McNicholl, J., Pociot, F., Hardt, C., et al. (1999) · Genes & Immunity · doi:10.1038/sj.gene.6363645 · Cited by 812
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity
King, C., Ilic, A., Koelsch, K., & Sarvetnick, N. (2004) · Cell · doi:10.1016/s0092-8674(04)00335-6 · Cited by 670
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
Rabinovitch, A., & Suarez-Pinzon, W. L. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00492-9 · Cited by 466
Self-citationMalonyl-CoA Signaling, Lipid Partitioning, and Glucolipotoxicity
Prentki, M., Joly, E., El-Assaad, W., & Roduit, R. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s405 · Cited by 431
Hassa, P. O., & Hottiger, M. O. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8527-2 · Cited by 427
Modulation of adipokines and cytokines in gestational diabetes and macrosomia
Atègbo, J.-M., Grissa, O., Yessoufou, A., Hichami, A., Dramane, K. L., Moutairou, K., Miled, A., Grissa, A., Jerbi, M., Tabka, Z., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0980 · Cited by 398
Daniel, D., & Wegmann, D. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.956 · Cited by 406
Daniel, D., Gill, R. G., Schloot, N., & Wegmann, D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250430 · Cited by 358
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.
André, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C., & Mathis, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2260 · Cited by 337
Mueller, R., Krahl, T., & Sarvetnick, N. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1093 · Cited by 306
The Role of Macrophages in T Cell–mediated Autoimmune Diabetes in Nonobese Diabetic Mice
Jun, H.-S., Yoon, C.-S., Zbytnuik, L., van Rooijen, N., & Yoon, J.-W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.347 · Cited by 279
Yessoufou, A., & Moutairou, K. (2011) · Experimental Diabetes Research · doi:10.1155/2011/218598 · Cited by 266
“Moreover, evidence from human and experimental models suggests that a shift between Th1 and Th2 cells may modulate the severity of type 1 diabetes [22, 41], in which Th1 cytokines are highly produced during the islet inflammatory response and may partially explain the ability of CD4+ T cells to cause β-cell destructio…”
BackgroundA new look at viruses in type 1 diabetes
Jun, H., & Yoon, J. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.337 · Cited by 268
Involvement of Oxidative Stress in the Pathogenesis of Diabetes
Kaneto, H., Katakami, N., Kawamori, D., Miyatsuka, T., Sakamoto, K., Matsuoka, T.-A., Matsuhisa, M., & Yamasaki, Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1465 · Cited by 263
Tian, J., Clere-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M. A., Mullen, Y., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1348 · Cited by 259
McGrowder, D., Ragoobirsingh, D., & Dasgupta, T. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0360 · Cited by 39
Metadata
- Authors
- Rabinovitch, A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1994-05-01
- Volume
- 43
- Issue
- 5
- Pages
- 613-621
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2035756597
- Cited by
- 374
- References
- 0
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.